Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Impacts of IPSS-m and conditioning intensity in allogeneic hematopoietic cell transplant for patients with myelodysplasia neoplasms

Zilu Zhang, Xiaoqian Xu, Qi Wen, Ruoxuan Zhang, Hongru Chen, Minli Hu, Chupeng Zhang, Chuanhe Jiang, Luxiang Wang, Jiayu Huang, Zengkai Pan, Hua Jin, Yanmin Zhao, Wei Shi, Xiao-Dong Mo, Yang Cao, Xiaoxia Hu

Blood (2025) 146 (Supplement 1): 1062.

https://doi.org/10.1182/blood-2025-1062

Published: 2025

Journal Articles

Interim results of a multi-center clinical trial evaluating copy number aberrations via shallow whole-genome sequencing (LeukoPrint) in Acute Myeloid Leukemia

Blood (2025) 146 (Supplement 1): 5245.

https://doi.org/10.1182/blood-2025-5245

Published: 2025

Journal Articles

Human intestinal acute graft-versus-host disease is governed by a subset of transition-like tissue-resident memory CD8+ T cells

Yiming Sun, Yutong Xue, Ruoyang Shao, Xinyu Liu, Chenyuyao Song, Zhiping Fan, Ren Lin, Na Xu, Qifa Liu, Hua Jin

Blood (2025) 146 (Supplement 1): 2453.

https://doi.org/10.1182/blood-2025-2453

Published: 2025

Journal Articles

Sorafenib enhances anti-leukemia effect via promoting macrophage-NK cell immune crosstalk in FLT3-ITD+ AML patients receiving allo-HSCT

Ruoyang Shao, Peiru Chi, Yuxin Bai, Fang Dai, Tian Zhang, Zhonghui Jiang, Xi Xu, Xiaofeng Yang, Kejing Li, Guo Qiu, Yueyang Zhong, Na Xu, Fen Huang, Zhiping Fan, Ren Lin, Hua Jin, Jing Sun, Qifa Liu, Xuan Li

Blood (2025) 146 (Supplement 1): 2308.

https://doi.org/10.1182/blood-2025-2308

Published: 2025

Journal Articles

Prognostic impact of transplant conditioning intensity (TCI) score and minimal identifiable disease (MID) in MDS: A multicenter trophy group study

Ruoxuan Zhang, Yang Cao, Hua Jin, Wei Shi, Xiaoxia Hu, Liang Huang

Blood (2025) 146 (Supplement 1): 4205.

https://doi.org/10.1182/blood-2025-4205

Published: 2025

Journal Articles

A first-in-class JAK/ROCK inhibitor, rovadicitinib, for glucocorticoid-refractory or -dependent chronic GVHD

Blood (2025) 145 (24): 2857–2872.

https://doi.org/10.1182/blood.2024026581

Published: 2025

Includes: Supplemental data

Journal Articles

Intensified Conditioning Containing Decitabine Versus Standard Myeloablative Conditioning for Adult Patients with KMT2A-Rearranged Leukemia: A Multicenter Retrospective Study

Zhongli Hu, Hai He, Shiqi Liu, Ying Dong, Zhiping Fan, Yiqing Li, Fen Huang, Na Xu, Can Liu, Yunxin Zeng, Ping Zhu, Ren Lin, Hua Jin, Xiong Zhang, Ruijuan Sun, Qifa Liu, Li Xuan

Blood (2024) 144 (Supplement 1): 2123.

https://doi.org/10.1182/blood-2024-202822

Published: 2024

Journal Articles

JAK/Rock Inhibitor Rovadicitinib for Glucocorticoid-Refractory or -Dependent Chronic Graft-Versus-Host Disease：Updated Results of Multicenter, Phase 1b/2a Trial

Blood (2024) 144 (Supplement 1): 97.

https://doi.org/10.1182/blood-2024-204703

Published: 2024

Journal Articles

Donor Neutrophil Subsets in G-CSF Mobilized Peripheral Blood Stem Cell to Predict the Risk of Agvhd

Haiyan Zhang, Qiaoyuan Wu, Huajuan Dai, Xinyu Liu, Zhiping Fan, Ren Lin, Na Xu, Qianwei Liu, Qifa Liu, Hua Jin

Blood (2024) 144 (Supplement 1): 4910.

https://doi.org/10.1182/blood-2024-204754

Published: 2024

Journal Articles

Signifcance of Intestinal CD8+CD69+CD103+ Tissue-Resident Memory T Cells in Human Intestinal Acute Graft-Versus-Host Disease

Yiming Sun, Yutong Xue, Ruoyang Shao, Zhiping Fan, Ren Lin, Fen Huang, Na Xu, Hua Jin

Blood (2024) 144 (Supplement 1): 4897.

https://doi.org/10.1182/blood-2024-202219

Published: 2024

Journal Articles

Increased EBV Infection and Relapse Rates Following Haploidentical Hematopoietic Cell Transplantation in the Era of Letermovir for Cytomegalovirus Prophylaxis: A Propensity Score Matching Analysis

Yifei Huang, Ren Lin, Shanyu Zhang, Zhiping Fan, Fen Huang, Li Xuan, Na Xu, Hui Liu, Zhixiang Wang, Min Dai, Hua Jin, Jing Sun, Qifa Liu

Blood (2024) 144 (Supplement 1): 4923.

https://doi.org/10.1182/blood-2024-202355

Published: 2024

Journal Articles

Homoharringtonine Overcomes the Negative Impact of Genetic Patterns on Venetoclax Plus Azacitidine Regimen in Relapsed/Refractory Acute Myeloid Leukemia: A Multi-Center, Cohort Study

Guopan Yu, Yu Zhang, Hua Jin, Zhao Yin, Guangyang Weng, Sijian Yu, Na Xu, Xin Du, Dongjun Lin, Jie Xiao, Zhiqiang Sun, Hongyu Zhang, Xinquan Liang, Ziwen Guo, Weihua Zhao, Min Dai, Xuejie Jiang, Li Xuan, Pengcheng Shi

Blood (2023) 142 (Supplement 1): 4262.

https://doi.org/10.1182/blood-2023-182847

Published: 2023

Journal Articles

Homoharringtonine Enhances the Anti-Leukemia Effect of Venetoclax in Acute Myeloid Leukemia with t(8;21)(q22;q22) Via Regulation of c-Myc/Bim Axis

Guopan Yu, Zhao Yin, Zurong Yao, Xiaqi Nie, Hua Jin, Yu Zhang, Dan Xu, Xuejie Jiang, Baohong Ping

Blood (2023) 142 (Supplement 1): 6038.

https://doi.org/10.1182/blood-2023-182668

Published: 2023

Journal Articles

Comparison of Two Venetoclax-Based Regimens As Salvage Therapies Bridged to Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Yiling Ye, Yanqiu Chen, Guopan Yu, Guangyang Weng, Qifa Liu, Hua Jin

Blood (2023) 142 (Supplement 1): 7104.

https://doi.org/10.1182/blood-2023-181616

Published: 2023

Journal Articles

MSCs-IL33-ILC2s-AREG-Tecs Axis Promotes the Remodeling of Thymic Function in Acute Gvhd

Jia-Bao He, Ke Zhao, Rongtao Xue, ShiQi Liu, YuTian Si, Hua Jin, Qifa Liu

Blood (2023) 142 (Supplement 1): 4923.

https://doi.org/10.1182/blood-2023-184615

Published: 2023

Journal Articles

Haploidentical Stem Cell Transplantation Had a Lower Incidence of Bronchiolitis Obliterans Syndrome Compared with HLA-Matched Sibling Transplantation for Patients with Hematologic Malignancies: Benefit from ATG?

Guangyang Weng, Zhiping Fan, Fen Huang, Na Xu, Hua Jin, Sijian Yu, Li Xuan, Qifa Liu

Blood (2022) 140 (Supplement 1): 12865–12866.

https://doi.org/10.1182/blood-2022-158753

Published: 2022

Journal Articles

Effect of Two Conditionings on Relapse in Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Blood (2022) 140 (Supplement 1): 2392.

https://doi.org/10.1182/blood-2022-158688

Published: 2022

Journal Articles

Prognosis of Amphotericin B in the Treatment of Breakthrough Candidemia in Patients with Hematologic Malignancies

Zherou He, Na Xu, Qifa Liu, Zhiping Fan, Fen Huang, Li Xuan, Hui Liu, Hua Jin, Jing Sun

Blood (2022) 140 (Supplement 1): 11190–11191.

https://doi.org/10.1182/blood-2022-162299

Published: 2022

Journal Articles

Influence of Molecular Abnormalities on Treatment Response of Venetoclax Plus Azacytidine and Homoharringtonine Versus Venetoclax Plus Hypomethylating Agent in Relapsed/Refractory Acute Myeloid Leukemia

Guopan Yu, Zhao Yin, Hua Jin, Sijian Yu, Yuhua Li, Danian Nie, Ziwen Guo, Zhiqiang Sun, Qingxiang Meng, Weihua Zhao, Dongjun Lin, Na Xu, Yu Zhang

Blood (2022) 140 (Supplement 1): 11796.

https://doi.org/10.1182/blood-2022-168004

Published: 2022

Journal Articles

Association of Genetic Characteristics with Response to Venetoclax Plus Hypomethylating Agents in Relapsed and Refractory Acute Myeloid Leukemia

Guangyang Weng, Yu Zhang, Guopan Yu, Na Xu, Zhiqiang Sun, Dongjun Lin, Xinquan Liang, Lan Deng, Jie Xiao, Hongyu Zhang, Ziwen Guo, Hua Jin, Xin Du, Qifa Liu

Blood (2022) 140 (Supplement 1): 2025–2026.

https://doi.org/10.1182/blood-2022-158762

Published: 2022

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Impacts of IPSS-m and conditioning intensity in allogeneic hematopoietic cell transplant for patients with myelodysplasia neoplasms

Interim results of a multi-center clinical trial evaluating copy number aberrations via shallow whole-genome sequencing (LeukoPrint) in Acute Myeloid Leukemia

Human intestinal acute graft-versus-host disease is governed by a subset of transition-like tissue-resident memory CD8+ T cells

Sorafenib enhances anti-leukemia effect via promoting macrophage-NK cell immune crosstalk in FLT3-ITD+ AML patients receiving allo-HSCT

Prognostic impact of transplant conditioning intensity (TCI) score and minimal identifiable disease (MID) in MDS: A multicenter trophy group study

A first-in-class JAK/ROCK inhibitor, rovadicitinib, for glucocorticoid-refractory or -dependent chronic GVHD

Intensified Conditioning Containing Decitabine Versus Standard Myeloablative Conditioning for Adult Patients with KMT2A-Rearranged Leukemia: A Multicenter Retrospective Study

JAK/Rock Inhibitor Rovadicitinib for Glucocorticoid-Refractory or -Dependent Chronic Graft-Versus-Host Disease：Updated Results of Multicenter, Phase 1b/2a Trial

Donor Neutrophil Subsets in G-CSF Mobilized Peripheral Blood Stem Cell to Predict the Risk of Agvhd

Signifcance of Intestinal CD8+CD69+CD103+ Tissue-Resident Memory T Cells in Human Intestinal Acute Graft-Versus-Host Disease

Increased EBV Infection and Relapse Rates Following Haploidentical Hematopoietic Cell Transplantation in the Era of Letermovir for Cytomegalovirus Prophylaxis: A Propensity Score Matching Analysis

Homoharringtonine Overcomes the Negative Impact of Genetic Patterns on Venetoclax Plus Azacitidine Regimen in Relapsed/Refractory Acute Myeloid Leukemia: A Multi-Center, Cohort Study

Homoharringtonine Enhances the Anti-Leukemia Effect of Venetoclax in Acute Myeloid Leukemia with t(8;21)(q22;q22) Via Regulation of c-Myc/Bim Axis

Comparison of Two Venetoclax-Based Regimens As Salvage Therapies Bridged to Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia

MSCs-IL33-ILC2s-AREG-Tecs Axis Promotes the Remodeling of Thymic Function in Acute Gvhd

Haploidentical Stem Cell Transplantation Had a Lower Incidence of Bronchiolitis Obliterans Syndrome Compared with HLA-Matched Sibling Transplantation for Patients with Hematologic Malignancies: Benefit from ATG?

Effect of Two Conditionings on Relapse in Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Prognosis of Amphotericin B in the Treatment of Breakthrough Candidemia in Patients with Hematologic Malignancies

Influence of Molecular Abnormalities on Treatment Response of Venetoclax Plus Azacytidine and Homoharringtonine Versus Venetoclax Plus Hypomethylating Agent in Relapsed/Refractory Acute Myeloid Leukemia

Association of Genetic Characteristics with Response to Venetoclax Plus Hypomethylating Agents in Relapsed and Refractory Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only